276 related articles for article (PubMed ID: 20636397)
1. Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases.
Marzano AV; Cugno M; Trevisan V; Fanoni D; Venegoni L; Berti E; Crosti C
Clin Exp Immunol; 2010 Oct; 162(1):100-7. PubMed ID: 20636397
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory cells, cytokines and matrix metalloproteinases in amicrobial pustulosis of the folds and other neutrophilic dermatoses.
Marzano AV; Cugno M; Trevisan V; Lazzari R; Fanoni D; Berti E; Crosti C
Int J Immunopathol Pharmacol; 2011; 24(2):451-60. PubMed ID: 21658319
[TBL] [Abstract][Full Text] [Related]
3. Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome.
Marzano AV; Fanoni D; Antiga E; Quaglino P; Caproni M; Crosti C; Meroni PL; Cugno M
Clin Exp Immunol; 2014 Oct; 178(1):48-56. PubMed ID: 24903614
[TBL] [Abstract][Full Text] [Related]
4. Histiocytoid Sweet's Syndrome: A localized cutaneous proliferation of macrophages frequently associated with chronic myeloproliferative disease.
Magro CM; Momtahen S; Nguyen GH; Wang X
Eur J Dermatol; 2015; 25(4):335-41. PubMed ID: 26067166
[TBL] [Abstract][Full Text] [Related]
5. Expression of MMP-9, MMP-10 and TNF-alpha and lack of epithelial MMP-1 and MMP-26 characterize pyoderma gangrenosum.
Bister V; Mäkitalo L; Jeskanen L; Saarialho-Kere U
J Cutan Pathol; 2007 Dec; 34(12):889-98. PubMed ID: 18001410
[TBL] [Abstract][Full Text] [Related]
6. Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis).
Marzano AV; Damiani G; Ceccherini I; Berti E; Gattorno M; Cugno M
Br J Dermatol; 2017 Jun; 176(6):1588-1598. PubMed ID: 27943240
[TBL] [Abstract][Full Text] [Related]
7. A Comprehensive Review of Neutrophilic Diseases.
Marzano AV; Borghi A; Wallach D; Cugno M
Clin Rev Allergy Immunol; 2018 Feb; 54(1):114-130. PubMed ID: 28688013
[TBL] [Abstract][Full Text] [Related]
8. Neutrophilic dermatoses and inflammatory bowel diseases.
Marzano AV; Menicanti C; Crosti C; Trevisan V
G Ital Dermatol Venereol; 2013 Apr; 148(2):185-96. PubMed ID: 23588144
[TBL] [Abstract][Full Text] [Related]
9. Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria.
Marzano AV; Ishak RS; Saibeni S; Crosti C; Meroni PL; Cugno M
Clin Rev Allergy Immunol; 2013 Oct; 45(2):202-10. PubMed ID: 23334898
[TBL] [Abstract][Full Text] [Related]
10. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
11. Neutrophilic dermatoses: a review of current treatment options.
Cohen PR
Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis.
Smeets TJ; Barg EC; Kraan MC; Smith MD; Breedveld FC; Tak PP
Ann Rheum Dis; 2003 Jul; 62(7):635-8. PubMed ID: 12810425
[TBL] [Abstract][Full Text] [Related]
13. Tumor Necrosis Factor-α and IL-17A Activation Induces Pericyte-Mediated Basement Membrane Remodeling in Human Neutrophilic Dermatoses.
Lauridsen HM; Pellowe AS; Ramanathan A; Liu R; Miller-Jensen K; McNiff JM; Pober JS; Gonzalez AL
Am J Pathol; 2017 Aug; 187(8):1893-1906. PubMed ID: 28609645
[TBL] [Abstract][Full Text] [Related]
14. Neutrophilic dermatosis: disease mechanism and treatment.
Maalouf D; Battistella M; Bouaziz JD
Curr Opin Hematol; 2015 Jan; 22(1):23-9. PubMed ID: 25394310
[TBL] [Abstract][Full Text] [Related]
15. Coexistence of pyoderma gangrenosum and sweet's syndrome in a patient with ulcerative colitis.
Ajili F; Souissi A; Bougrine F; Boussetta N; Abdelhafidh NB; Sayhi S; Louzir B; Doss N; Laabidi J; Othmani S
Pan Afr Med J; 2015; 21():151. PubMed ID: 26327988
[TBL] [Abstract][Full Text] [Related]
16. T helper type 1-related molecules as well as interleukin-15 are hyperexpressed in the skin lesions of patients with pyoderma gangrenosum.
Antiga E; Maglie R; Volpi W; Bianchi B; Berti E; Marzano AV; Caproni M
Clin Exp Immunol; 2017 Sep; 189(3):383-391. PubMed ID: 28518224
[TBL] [Abstract][Full Text] [Related]
17. A continuum of neutrophilic disease occurring in a patient with ulcerative colitis.
Salmon P; Rademaker M; Edwards L
Australas J Dermatol; 1998 May; 39(2):116-8. PubMed ID: 9611384
[TBL] [Abstract][Full Text] [Related]
18. Potential correlation of wound bed score and biomarkers in chronic lower leg wounds: an exploratory study.
Dini V; Papadia F; Francesco FD; Salvo P; Paolicchi A; Janowska A; Chiricozzi A; Oranges T
J Wound Care; 2017 Sep; 26(Sup9):S9-S17. PubMed ID: 28880755
[TBL] [Abstract][Full Text] [Related]
19. Evidence of inflammatory cell involvement in brain arteriovenous malformations.
Chen Y; Zhu W; Bollen AW; Lawton MT; Barbaro NM; Dowd CF; Hashimoto T; Yang GY; Young WL
Neurosurgery; 2008 Jun; 62(6):1340-9; discussion 1349-50. PubMed ID: 18825001
[TBL] [Abstract][Full Text] [Related]
20. Characterizing the presence of neutrophil extracellular traps in neutrophilic dermatoses.
Eid E; Safi R; El Hasbani G; Aftimos V; Abbas O; Kibbi AG; Nassar D
Exp Dermatol; 2021 Jul; 30(7):988-994. PubMed ID: 33969538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
